Author:
Chen Wei,Liu Yan,Xue Guoyu,Zhang Lisi,Zhang Lei,Shao Suxia
Funder
the Nature Science Foundation of Hebei Province
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res. 2013;4(1):76–88. doi: 10.1007/s12975-012-0251-0 .
2. Hua P, Tao J, Liu JY, Yang SR. Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor. Int J Clin Exp Pathol. 2014;7(11):7782–8.
3. Niagara MI, Haider H, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res. 2007;100(4):545–55. doi: 10.1161/01.RES.0000258460.41160.ef .
4. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93–8.
5. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003;41(5):879–88.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献